Skip to content
TrackPodcasts
businessMar 12, 20261:03

Tariff Cost Could Eat Your Bigger Tax Refund 3/12/26

About this episode

Your 60-second money minute. Today's topic: Tariff Cost Could Eat Your Bigger Tax Refund


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Your Money Minute publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

Transcript ready

68 searchable segments. Every word is indexed and playable.

Tariff Cost Could Eat Your Bigger Tax Refund 3/12/26

Your Money Minute

0:00
1:03

Full transcript

Your Money MinuteTariff Cost Could Eat Your Bigger Tax Refund 3/12/26. Machine-transcribed; use the interactive transcript above to jump the player to any line.

with a CNBC, your money minute. I'm Jessica Edinger. Americans are getting bigger tax refunds this year than in previous years and businesses. We're hoping they're going to spend that. Walmart surveys indicate that it's more it's going to be dedicated to savings, but historical behavior would tell you otherwise. That's JP Morgan's Chris Horvors on CNBC. If you look back over the history of the consumer in the U.S., they get free money. They spend that money. But here's a surprise about your bigger tax refund for this spring. The Trump tariffs are sending prices just about that much higher. So it's just about a wash. People are going to see their tax refunds an average of $1,000 higher, but the tariffs are moving in the exact opposite direction. The tariffs are eating directly into that and that could go up to 1,300 that the tariffs are eating into American households spending. The Tax Foundation's Daniel Bunn on CNBC. Keep up on taxes and tariffs at CNBC.com.

I'm Jessica Edinger, CNBC. Snoring, gasping during sleep, feeling fatigued? Wake up to Zepbound, Terzepatide. The first and only FDA approved prescription medicine for moderate to severe obstructive sleep apnea, OSA, and adults with obesity. Zepbound is an injectable prescription medicine that may help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. Zepbound should be used with a reduced calorie diet and increased physical activity. Zepbound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection. Zepbound contains Terzepatide and should not be used with other Terzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children. Do not share needles or pens or reuse needles. Don't take Zepbound if allergic to it or if you or someone in your family had medullary thyroid cancer or multiple endocrine neoplasia syndrome type two. Tell your doctor if you get a lump or swelling in your neck. Stop Zepbound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas

or gallbladder problems. Tell your doctor if you experience vision changes, depression, or suicidal thoughts before schedule procedures with anesthesia. If you're nursing, pregnant, planned to be or taking birth control pills, taking Zepbound with a sulfonoluria or insulin may cause a little blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems. Talk to your doctor, call 1-800-545-5979 or visit zepbound.lily.com. Zepbound and its delivery device base in QuickPin are registered trademarks owned or licensed by Eli Lilly and Company. It's subsidiaries or affiliates.

More episodes

More from Your Money Minute

View all episodes →